Open Access

Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions

Event: ESC Congress 2021 - The Digital Experience
Topic: Valvular Heart Disease
Session type: Tutorials
Sponsored by Bristol Myers Squibb and Pfizer
Date: 28 August 2021
Time: 13:15 - 14:15

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

1 presentations in this session

Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions.

Speaker: Professor A. Banning (Oxford, GB)
Speaker: Doctor B. Gonska (Ulm, DE)
Thumbnail

2 speakers from this session

Professor Adrian Paul Banning

John Radcliffe Hospital, Oxford (United Kingdom of Great Britain & Northern Ireland)
7 presentations
0 follower

Doctor Birgid Gonska

University of Ulm, Ulm (Germany)
2 presentations
0 follower

Related content

ESC Premium Access

Myocarditis associated with COVID vaccines

4 December 2021

This platform is supported by

logo Novo Nordisk